Hologic : Receives Innovative Technology Contract From Vizient for CoolSeal® Advanced Energy Portfolio and JustRight® 5 mm Stapler
April 16, 2024 at 08:03 am EDT
Share
Hologic Receives Innovative Technology Contract From Vizient for CoolSeal® Advanced Energy Portfolio and JustRight® 5 mm Stapler
Hologic Receives Innovative Technology Contract From Vizient for CoolSeal® Advanced Energy Portfolio and JustRight® 5 mm Stapler
New Contract Expands Access to Hologic's Innovative Surgical Portfolio
MARLBOROUGH, Mass., April 16, 2024 - Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, has received an Innovative Technology contract fromVizient, Inc.,the United States' largest provider-driven healthcare performance improvement company, for its CoolSeal® advanced energy portfolio and JustRight® 5 mm stapler. Vizient awarded the contract after hospital experts who served on one of its customer-led councils recommended CoolSeal and JustRight.
These customer-led councils evaluate products submitted through Vizient'sInnovative Technology Program. They recommend contracts for technologies that have the potential to enhance clinical care, patient safety and healthcare worker safety, or to improve business operations of healthcare organizations.
"We are honored to be recognized by Vizient's team of experts with this Innovative Technology contract," said Brandon Schnittker, President of Surgical Solutions at Hologic. "This contract underscores Hologic's commitment to innovation and enhancing patient care and allows us to expand the reach of our vessel sealing portfolio and laparoscopic stapling device to ensure more surgeons and patients can benefit from the technologies."
Attachments
Original Link
Permalink
Disclaimer
Hologic Inc. published this content on
16 April 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
16 April 2024 12:02:02 UTC.
Hologic, Inc. is the world leader in the design, manufacturing and marketing of diagnostic products, medical imaging systems and surgical products dedicated to women's health. Net sales break down by area of application as follows:
- molecular diagnostics (46.7%): rapid diagnostic tests for human diseases detection (sexually transmitted infections, respiratory diseases, viral diseases, infectious diseases, cancers of the cervix and prostate, etc.) and fetal fibronectin;
- breast health (35.5%): digital mammography and breast biopsy solutions and systems;
- gynecological surgery (15%): endometrial ablation devices, minimally invasive intervention systems for the hysteroscopic elimination of targeted intrauterine diseases (including fibroids and polyps). The group also offers fluid management systems for use in hysteroscopic procedures;
- bone health (2.8%): bone imaging systems, bone sonometers and osteodensitometers for bone structure and density, and osteoporotic fractures risk assessment.
Net sales break down by source of revenue between sales of products (81.4%) and services (18.6%).
Net sales are distributed geographically as follows: the United States (75.9%), Europe (12.9%), Asia/Pacific (6.3%) and other (4.9%).
HOLOGIC, INC. 
